Shanghai Baoshan Center for Disease Control and Prevention, Shanghai, 201901, China.
Clinical Research Center, Shanghai Baoshan Luodian Hospital, No. 121 Luoxi Road, Baoshan District, Shanghai, 201908, China.
J Orthop Surg Res. 2023 Mar 30;18(1):261. doi: 10.1186/s13018-023-03754-0.
Deregulation of lncRNAs has been observed in human osteosarcoma. This study explored the diagnostic and prognostic significance of EPB41L4A-AS1 and UNC5B-AS1 in osteosarcoma.
Relative levels of EPB41L4A-AS1 and UNC5B-AS1 were detected in osteosarcoma tissue samples and cells. The ability to distinguish osteosarcoma from health was assessed by receiver operating characteristic (ROC) curve construction. Kaplan-Meier (K-M) and Cox proportional-hazards analyses were performed for prognosis factors. The bioinformatics approach was used to identify targeting miRNA for EPB41L4A-AS1 and UNC5B-AS1. Kaplan-Meier survival curves and Whitney Mann U tests were conducted for validating the statistical significance. In cell culture experiments, the influence of EPB41L4A-AS1 and UNC5B-AS1 on proliferation, migration, and invasion of the osteosarcoma cell line was examined by CCK-8 and Transwell assays.
Levels of EPB41L4A-AS1 and UNC5B-AS1 were upregulated in osteosarcoma patients and cells compared with the healthy participants and normal cell lines. EPB41L4A-AS1 and UNC5B-AS1 have a potent ability to distinguish the patients with osteosarcoma from the health. EPB41L4A-AS1 and UNC5B-AS1 levels correlated with SSS stage. Patients with high levels of EPB41L4A-AS1 and UNC5B-AS1 had significantly shorter survival times. EPB41L4A-AS1 and UNC5B-AS1 were independent prognostic indexes for overall survival. miR-1306-5p was a common target for EPB41L4A-AS1 and UNC5B-AS1. A propulsive impact on cell proliferation, migration, and invasion by EPB41L4A-AS1 and UNC5B-AS1 was observed, but can be rescued by miR-1306-5p.
It was concluded that upregulations of EPB41L4A-AS1 and UNC5B-AS1 expression were diagnostic and prognostic biomarkers for human osteosarcoma. EPB41L4A-AS1 and UNC5B-AS1 contribute to the biological behavior of osteosarcoma via miR-1306-5p.
长链非编码 RNA 的失调已在人类骨肉瘤中观察到。本研究探讨了 EPB41L4A-AS1 和 UNC5B-AS1 在骨肉瘤中的诊断和预后意义。
检测骨肉瘤组织样本和细胞中 EPB41L4A-AS1 和 UNC5B-AS1 的相对水平。通过构建接收器工作特征(ROC)曲线评估区分骨肉瘤与健康的能力。进行 Kaplan-Meier(K-M)和 Cox 比例风险分析以确定预后因素。采用生物信息学方法鉴定 EPB41L4A-AS1 和 UNC5B-AS1 的靶向 miRNA。进行 Kaplan-Meier 生存曲线和 Whitney Mann U 检验以验证统计意义。在细胞培养实验中,通过 CCK-8 和 Transwell 测定检查 EPB41L4A-AS1 和 UNC5B-AS1 对骨肉瘤细胞系增殖、迁移和侵袭的影响。
与健康参与者和正常细胞系相比,骨肉瘤患者和细胞中 EPB41L4A-AS1 和 UNC5B-AS1 的水平上调。EPB41L4A-AS1 和 UNC5B-AS1 具有区分骨肉瘤患者与健康人群的强大能力。EPB41L4A-AS1 和 UNC5B-AS1 水平与 SSS 分期相关。EPB41L4A-AS1 和 UNC5B-AS1 水平高的患者生存时间明显缩短。EPB41L4A-AS1 和 UNC5B-AS1 是总生存期的独立预后指标。miR-1306-5p 是 EPB41L4A-AS1 和 UNC5B-AS1 的共同靶标。EPB41L4A-AS1 和 UNC5B-AS1 观察到对细胞增殖、迁移和侵袭的推进作用,但可被 miR-1306-5p 挽救。
上调 EPB41L4A-AS1 和 UNC5B-AS1 的表达是人类骨肉瘤的诊断和预后生物标志物。EPB41L4A-AS1 和 UNC5B-AS1 通过 miR-1306-5p 促进骨肉瘤的生物学行为。